No products in the cart.
Pre-made Bersanlimab benchmark antibody ( Whole mAb, anti-ICAM1 therapeutic antibody, Anti-BB2/CD54/P3.58 Antibody) for drug discovery and mechanism of action (MOA) research
Cat:GMP-Bios-ab-064
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Pre-Made Bersanlimab biosimilar, Whole mAb, Anti-ICAM1 Antibody: Anti-BB2/CD54/P3.58 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
| Products Name (INN Index) | Pre-Made Bersanlimab biosimilar, Whole mAb, Anti-ICAM1 Antibody: Anti-BB2/CD54/P3.58 therapeutic antibody |
|---|---|
| INN Name | Bersanlimab |
| Target | ICAM1 |
| Format | Whole mAb |
| Derivation | Human |
| Species Reactivity | Human |
| CH1 Isotype | IgG1 |
| VD LC | Lambda |
| Highest_Clin_Trial (Jan '20) | Phase-II |
| Est. Status | Discontinued |
| 100% SI Structure | None |
| 99% SI Structure | None |
| 95-98% SI Structure | None |
| Year Proposed | 2017 |
| Year Recommended | 2018 |
| Companies | BioInvent International |
| Conditions Approved | NA |
| Conditions Active | NA |
| Conditions Discontinued | Multiple myeloma |
| Development Tech | n-CoDeR |
| Previous Name | NA |
| Gm Offical Target Name | ICAM1 |
| Package |
Previous slide
Next slide
